Kathryn Feigenbaum

516 total citations
14 papers, 383 citations indexed

About

Kathryn Feigenbaum is a scholar working on Molecular Biology, Epidemiology and General Health Professions. According to data from OpenAlex, Kathryn Feigenbaum has authored 14 papers receiving a total of 383 indexed citations (citations by other indexed papers that have themselves been cited), including 5 papers in Molecular Biology, 4 papers in Epidemiology and 3 papers in General Health Professions. Recurrent topics in Kathryn Feigenbaum's work include PI3K/AKT/mTOR signaling in cancer (5 papers), Neuroendocrine Tumor Research Advances (4 papers) and Polyamine Metabolism and Applications (2 papers). Kathryn Feigenbaum is often cited by papers focused on PI3K/AKT/mTOR signaling in cancer (5 papers), Neuroendocrine Tumor Research Advances (4 papers) and Polyamine Metabolism and Applications (2 papers). Kathryn Feigenbaum collaborates with scholars based in United States and Israel. Kathryn Feigenbaum's co-authors include Robert T. Jensen, David C. Metz, Joseph R. Pisegna, David Venzon, Richard V. Benya, Doris B. Strader, Praveen K. Roy, Showkat Bashir, Jeremiah V. Ojeaburu and Vitaly A. Fishbeyn and has published in prestigious journals such as Gastroenterology, Medicine and Alimentary Pharmacology & Therapeutics.

In The Last Decade

Kathryn Feigenbaum

14 papers receiving 353 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Kathryn Feigenbaum United States 8 257 156 126 111 89 14 383
Carlos Fernández‐Carrillo Spain 11 213 0.8× 22 0.1× 35 0.3× 66 0.6× 23 0.3× 29 364
Sara Cococcia Italy 10 90 0.4× 10 0.1× 16 0.1× 137 1.2× 29 0.3× 20 330
Theodoros Angelopoulos Greece 7 59 0.2× 26 0.2× 44 0.3× 21 0.2× 8 0.1× 11 158
Timothy W. Bodnar United States 6 50 0.2× 26 0.2× 30 0.2× 39 0.4× 53 0.6× 10 306
Gift Mulima Malawi 11 27 0.1× 15 0.1× 40 0.3× 99 0.9× 30 0.3× 31 251
Deirdre E. Donnelly United Kingdom 7 72 0.3× 18 0.1× 11 0.1× 23 0.2× 51 0.6× 17 252
B. Joseph Elmunzer United States 8 28 0.1× 10 0.1× 193 1.5× 202 1.8× 29 0.3× 15 442
Nasir Khokhar Pakistan 12 343 1.3× 5 0.0× 31 0.2× 60 0.5× 13 0.1× 43 483
Hyung Taek Lim South Korea 8 88 0.3× 30 0.2× 89 0.7× 24 0.2× 10 0.1× 8 339
Sumanth Khadke United States 9 26 0.1× 33 0.2× 32 0.3× 38 0.3× 68 0.8× 29 323

Countries citing papers authored by Kathryn Feigenbaum

Since Specialization
Citations

This map shows the geographic impact of Kathryn Feigenbaum's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Kathryn Feigenbaum with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Kathryn Feigenbaum more than expected).

Fields of papers citing papers by Kathryn Feigenbaum

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Kathryn Feigenbaum. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Kathryn Feigenbaum. The network helps show where Kathryn Feigenbaum may publish in the future.

Co-authorship network of co-authors of Kathryn Feigenbaum

This figure shows the co-authorship network connecting the top 25 collaborators of Kathryn Feigenbaum. A scholar is included among the top collaborators of Kathryn Feigenbaum based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Kathryn Feigenbaum. Kathryn Feigenbaum is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

14 of 14 papers shown
1.
Brennan, Caitlin W., et al.. (2018). Patient Acuity Related to Clinical Research: Concept Clarification and Literature Review. Western Journal of Nursing Research. 41(9). 1306–1331. 6 indexed citations
2.
Fisher, Cheryl, Georgie Cusack, Kim J. Cox, Kathryn Feigenbaum, & Gwenyth R. Wallen. (2016). Developing Competency to Sustain Evidence-Based Practice. JONA The Journal of Nursing Administration. 46(11). 581–585. 16 indexed citations
3.
Fisher, Cheryl & Kathryn Feigenbaum. (2015). Harnessing technology to promote patient-centered care. Nursing Management. 46(1). 14–15. 3 indexed citations
4.
Shelburne, Nonniekaye, et al.. (2010). Use Of An Education Intervention In Improving Blood Glucose Management In Patients Undergoing Allogeneic Blood And Marrow Transplantation (BMT). Biology of Blood and Marrow Transplantation. 16(2). S195–S195. 1 indexed citations
5.
Feigenbaum, Kathryn, et al.. (2010). Management of the Metabolic Syndrome in Patients With Human Immunodeficiency Virus. The Diabetes Educator. 36(3). 457–464. 7 indexed citations
6.
Feigenbaum, Kathryn. (2006). Update on Gastroparesis. Gastroenterology Nursing. 29(3). 239–244. 6 indexed citations
7.
Roy, Praveen K., David Venzon, Kathryn Feigenbaum, et al.. (2001). Gastric Secretion in Zollinger-Ellison Syndrome. Medicine. 80(3). 189–222. 95 indexed citations
8.
Feigenbaum, Kathryn, et al.. (1998). ALARA Study of Teaching Effectiveness on Reducing Radiation Exposure. Gastroenterology Nursing. 21(6). 234–238. 4 indexed citations
9.
Allen, Mary J., et al.. (1997). A guide to noninvasive intermittent ventilatory support. Heart & Lung. 26(4). 307–316. 4 indexed citations
10.
Feigenbaum, Kathryn. (1995). Case Studies as a Research Method. Gastroenterology Nursing. 18(2). 54–56. 10 indexed citations
11.
Metz, David C., et al.. (1993). Use of omeprazole in Zollinger‐Ellison syndrome: a prospective nine‐year study of efficacy and safety. Alimentary Pharmacology & Therapeutics. 7(6). 597–610. 71 indexed citations
12.
Metz, David C., Joseph R. Pisegna, Kathryn Feigenbaum, et al.. (1993). Prospective study of efficacy and safety of lansoprazole in Zollinger-Ellison syndrome. Digestive Diseases and Sciences. 38(2). 245–256. 46 indexed citations
13.
Jensen, Robert T., et al.. (1993). Prospective study of the long‐term efficacy and safety of lansoprazole in patients with the Zollinger‐Ellison syndrome. Alimentary Pharmacology & Therapeutics. 7(s1). 41–50. 32 indexed citations
14.
Metz, David C., Joseph R. Pisegna, Vitaly A. Fishbeyn, et al.. (1992). Currently used doses of omeprazole in Zollinger-Ellison syndrome are too high. Gastroenterology. 103(5). 1498–1508. 82 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026